« Previous Next » Neurobiology of Aging
Volume 31, Issue 4 , Pages 539-540 , April 2010

Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

Maartje I. Kester
- Alzheimer Center and Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands
- Corresponding author. Tel.: +31 20 4440685; fax: +31 20 4440715.
Nicolaas A. Verwey
- Alzheimer Center and Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands
- Department of Clinical Chemistry, VU University Medical Centre, Amsterdam, The Netherlands
Evert J. van Elk
- Department of Clinical Chemistry, VU University Medical Centre, Amsterdam, The Netherlands
Philip Scheltens
- Alzheimer Center and Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands
Marinus A. Blankenstein
- Department of Clinical Chemistry, VU University Medical Centre, Amsterdam, The Netherlands

Received 28 June 2008

References

Bouwman FH, Schoonenboom SN, van der Flier WM, van Elk EJ, Kok A, Barkhof F, et al. CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment. Neurobiol. Aging. 2007;28:1070–1074
Hansson, O., Zetterberg, H., Vanmechelen, E., Vanderstichele, H., Andreasson, U., Londos, E., Wallin, A., Minthon, L., Blennow, K., 2008. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neurobiol. Aging 2008. doi:10.1016/j.neurobiolaging.2008.03.027.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Stadlan, E.M., 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939–944.